<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15365">Acetylsalicylic acid</z:chebi> (<z:chebi fb="37" ids="15365">ASA</z:chebi>; Aspirin) has a neuroprotective potential by its anti-excitotoxic and anti-inflammatory effects </plain></SENT>
<SENT sid="1" pm="."><plain>A temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) model was used in 80 Wistar rats to evaluate whether a high dose of Aspirin (40 mg/kg) applied with different initiation time points after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> (30 min, 3 h, 6 h, 12 h, 20 rats for each time group) and followed by repeated administration (1, 2 and 3 days) is neuroprotective </plain></SENT>
<SENT sid="2" pm="."><plain>Neurological score and brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume were analyzed and indicated that postischemic therapy initiation at 30 min and as late as 6 h led to better neurological recovery (6 h, p=0.0046) and significant smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> size (6 h, 57+/-9 mm(3), n=10, p=0.0043) compared to the saline control group (110+/-13 mm(3), n=10) </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, there may be a relatively wide time window for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> therapy with high dose Aspirin </plain></SENT>
</text></document>